FMA Advisory’s Bristol-Myers Squibb BMY Stock Holding History

FMA Advisory’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$1.32M	Sell	22,326 -607	-3%	-$40K	0.49%	67
2021 Q2	$1.53M	Buy	22,933 +74	+0.3%	+$4.83K	0.57%	65
2021 Q1	$1.44M	Sell	22,859 -643	-3%	-$40K	0.45%	81
2020 Q4	$1.46M	Buy	23,502 +128	+0.5%	+$7.87K	0.49%	73
2020 Q3	$1.41M	Buy	23,374 +1,010	+5%	+$60.8K	0.56%	62
2020 Q2	$1.31M	Buy	22,364 +453	+2%	+$27.1K	0.59%	58
2020 Q1	$1.22M	Sell	21,911 -1,106	-5%	-$67.6K	0.66%	51
2019 Q4	$1.48M	Buy	23,017 +6,209	+37%	+$356K	0.59%	56
2019 Q3	$852K	Buy	+16,808	New	+$790K	0.37%	81
2015 Q2	$47K	Buy	+703	New	+$46.3K	0.03%	199
2013 Q3	–	Sell	-4,854	Closed	-$217K	–	173
2013 Q2	$217K	Buy	+4,854	New	+$211K	0.09%	160

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

FMA Advisory's BMY Position: Q3 2021 in Review

FMA Advisory reduced its Bristol-Myers Squibb (BMY) stake by 2.6% in Q3 2021, selling an estimated $40K and leaving 22,326 shares worth $1.32M. The position accounts for 0.49% of the portfolio, ranked #67.

FMA Advisory first reported a position in BMY in Q2 2013 and has held it in 11 quarters since. The position peaked at $1.53M in Q2 2021. 2,292 funds tracked by Wall St. Rank hold BMY as of Q3 2021.

FMA Advisory held 22,326 shares of Bristol-Myers Squibb worth $1.32M as of Q3 2021.
FMA Advisory sold 607 Bristol-Myers Squibb shares in Q3 2021, an estimated $40K.
Bristol-Myers Squibb made up 0.49% of FMA Advisory's portfolio in Q3 2021, its #67 holding.
FMA Advisory first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 11 quarters since.
FMA Advisory's Bristol-Myers Squibb position peaked at $1.53M in Q2 2021.
2,292 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2021.

Based on FMA Advisory's 13F filing for Q3 2021, filed 15 Nov 2021.